This protocol is judged by an institutional critique board, an impartial group that critiques any clinical trials involving individuals. If a analyze will involve a Routine I drug, as soon as the board approves the protocol as moral, the scientists really need to make an application for an investigational new drug (IND) variety from the FDA.copyrig